Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-011587
Filing Date
2023-04-07
Accepted
2023-04-07 17:00:25
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 128053
2 ex3-1.htm EX-3.1 123655
3 ex4-2.htm EX-4.2 49803
4 ex31-1.htm EX-31.1 6188
5 ex31-2.htm EX-31.2 5926
  Complete submission text file 0001493152-23-011587.txt   669976

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE celc-20221231.xsd EX-101.SCH 26029
7 XBRL LABEL FILE celc-20221231_lab.xml EX-101.LAB 98919
8 XBRL PRESENTATION FILE celc-20221231_pre.xml EX-101.PRE 23746
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 7008
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38207 | Film No.: 23809165
SIC: 8071 Services-Medical Laboratories